ATLANTA--(BUSINESS WIRE)--Capsalus Corp. (OTCBB:WELL) has completed the acquisition of the stock of GeneWize Life Sciences, Inc., the wholly-owned direct-selling subsidiary of GeneLink Biosciences, Inc. (OTCBB:GNLK), a leader in consumer genomics. The deal will provide immediate revenues.
